Abstract

Platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) have become increasingly important regenerative therapies within aesthetic medicine. Their popularity stems from their autologous origin, favourable safety profile and ability to stimulate tissue repair, angiogenesis, collagen synthesis and cellular regeneration. More recently, second-generation platelet concentrates including PRF, injectable PRF (i-PRF) and concentrated growth factors (CGF) have expanded the therapeutic options available to aesthetic practitioners. This review evaluates current evidence regarding the use of platelet concentrates in facial rejuvenation, acne scar management, skin quality improvement and androgenetic alopecia, with particular emphasis on combination therapies involving microneedling, micropricking and nano-peeling procedures. Current evidence suggests that platelet concentrates are effective regenerative adjuncts that consistently demonstrate enhanced outcomes when combined with collagen-induction therapies. Although variability in preparation protocols remains a major limitation, the literature supports the integration of PRP and PRF into evidence-based aesthetic practice.

Introduction

Regenerative medicine has transformed aesthetic practice by shifting treatment objectives from simple correction of ageing changes towards biological tissue restoration. Among the most widely utilised regenerative therapies are platelet-rich plasma (PRP) and platelet-rich fibrin (PRF), both of which are derived from autologous blood and contain high concentrations of growth factors capable of stimulating tissue repair and regeneration.

PRP is a plasma fraction containing platelet concentrations significantly higher than those found in whole blood. Following activation, platelets release numerous bioactive molecules including platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGF-β), epidermal growth factor (EGF), fibroblast growth factor (FGF) and insulin-like growth factor-1 (IGF-1) (Mercuri et al., 2021; Zhong et al., 2026). These growth factors play critical roles in angiogenesis, fibroblast proliferation, collagen synthesis and extracellular matrix remodelling.

PRF was subsequently developed as a second-generation platelet concentrate designed to overcome some limitations of traditional PRP. Unlike PRP, PRF contains a fibrin matrix that acts as a biological scaffold, allowing slower and more sustained release of growth factors. Injectable PRF (i-PRF) and concentrated growth factors (CGF) represent further developments in platelet-concentrate technology and may offer enhanced regenerative potential.

The expanding use of platelet concentrates has coincided with increased adoption of collagen-induction therapies such as microneedling, micropricking and nano-peeling. Combining these modalities has become increasingly popular due to their complementary mechanisms of action and potential synergistic effects.

Biological Mechanisms of Action

The regenerative effects of PRP and PRF are mediated through multiple biological pathways. Upon activation, platelets release growth factors stored within alpha granules, initiating cellular responses that promote healing and regeneration.

These growth factors stimulate fibroblast proliferation, angiogenesis and collagen synthesis while simultaneously modulating inflammation. Research has demonstrated activation of several signalling pathways including Wnt/β-catenin, MAPK, Akt/ERK and Notch pathways, all of which contribute to tissue regeneration and hair follicle development (Zhong et al., 2026).

PRP also appears to exert anti-apoptotic effects through upregulation of Bcl-2 proteins and activation of β-catenin signalling, promoting cell survival and tissue repair. These mechanisms are particularly relevant in hair restoration, where preservation of dermal papilla cell viability is essential for follicular regeneration.

PRF differs biologically from conventional PRP because the fibrin matrix acts as a scaffold that gradually releases growth factors over days rather than hours. This prolonged release profile may enhance tissue regeneration and provide more sustained stimulation of healing pathways. Injectable PRF combines this biological advantage with the practicality of injectable delivery, making it increasingly attractive in aesthetic medicine.

Standardisation Challenges

Despite widespread clinical use, one of the greatest limitations within the PRP literature remains the lack of standardisation. Kramer and Keaney (2018) found considerable variation in preparation protocols across studies, with only a minority reporting complete methodological details. Variability exists in blood volume collection, centrifugation speed, centrifugation duration, platelet concentration, activation methods and treatment schedules.

These inconsistencies create significant challenges when comparing studies and contribute to variable clinical outcomes. Similar concerns have been raised in more recent reviews, which continue to identify heterogeneity in preparation methods as a major obstacle to establishing evidence-based treatment protocols (Zhong et al., 2026).

Until standardised protocols are developed, interpretation of efficacy data should be undertaken cautiously. Nevertheless, despite methodological variability, the overall direction of evidence remains favourable.

Facial Rejuvenation

Facial rejuvenation represents one of the most common aesthetic applications of platelet concentrates. The procedure commonly known as the “vampire facial” combines microneedling with topical PRP application and has become widely recognised by both practitioners and patients.

Clinical studies have reported improvements in skin texture, elasticity, hydration, fine wrinkles and overall skin quality following PRP treatment. These effects are attributed to enhanced collagen production, neovascularisation and extracellular matrix remodelling.

Systematic reviews evaluating PRP for facial rejuvenation have demonstrated moderate-quality evidence supporting improvements in skin texture, superficial rhytides and tissue quality. Patients frequently report improvements in skin brightness, firmness and overall appearance following treatment.

PRF has also shown promising results in facial rejuvenation. The sustained release of growth factors from the fibrin matrix may provide longer-lasting biological stimulation compared with conventional PRP. Clinical studies evaluating injectable PRF have reported improvements in periorbital rejuvenation, skin density and elasticity.

Although PRF remains less extensively studied than PRP, emerging evidence suggests that it may offer biological advantages, particularly in areas requiring prolonged regenerative stimulation.

Acne Scar Management

Acne scarring remains one of the most challenging conditions encountered in aesthetic practice. The pathophysiology involves collagen destruction, dermal remodelling and tissue volume loss, making regenerative therapies particularly attractive.

PRP has demonstrated significant efficacy in acne scar treatment through stimulation of fibroblast activity, collagen deposition and extracellular matrix remodelling. Several systematic reviews and meta-analyses have concluded that PRP improves scar appearance, skin texture and patient satisfaction.

The strongest evidence supports PRP when combined with microneedling. A meta-analysis published in 2022 demonstrated significantly greater improvements in scar severity and patient satisfaction when PRP was added to microneedling protocols compared with microneedling alone.

PRP also appears to accelerate healing and reduce post-procedure inflammation, shortening recovery times and improving patient experience. These benefits have led many practitioners to incorporate PRP routinely into acne scar treatment protocols.

More recently, combination approaches involving PRP and autologous fibroblasts have demonstrated promising outcomes. Zare et al. (2025) reported significant improvements in skin thickness, elasticity, hydration and scar volume when fibroblast therapy was combined with PRP compared with PRP alone, suggesting that regenerative combination therapies may represent the future of acne scar management.

Microneedling, Micropricking and Nano-Peeling

Among all aesthetic applications, combination therapies involving platelet concentrates and collagen-induction procedures appear to produce the most consistent results.

Microneedling creates controlled micro-injuries within the skin, triggering wound-healing cascades and stimulating neocollagenesis. The addition of PRP or PRF enhances these processes by delivering concentrated growth factors directly into the treatment area.

Micropricking operates on similar principles but may provide greater control over treatment depth and tissue targeting. Nano-peeling, meanwhile, produces superficial epidermal disruption with minimal downtime while enhancing transdermal penetration of biologically active substances.

Several mechanisms explain the enhanced efficacy observed with combination therapies. First, microneedling creates microchannels that facilitate penetration of growth factors. Second, controlled tissue injury stimulates the body’s natural repair mechanisms. Third, platelet concentrates provide additional biological stimulation through growth-factor delivery.

Clinical studies consistently demonstrate superior outcomes with combination approaches compared with monotherapy. Improvements have been reported in skin texture, elasticity, pigmentation, acne scarring and overall patient satisfaction.

The Indian Association of Dermatologists concluded that PRP demonstrates greatest efficacy when combined with other collagen-induction procedures rather than when used alone (Dhurat et al., 2021). Similar conclusions have been reached by multiple systematic reviews, supporting combination therapy as the preferred treatment strategy.

Hair Restoration and Scalp Rejuvenation

Hair restoration represents one of the most extensively researched applications of platelet concentrates and currently provides some of the strongest evidence supporting their clinical use.

Androgenetic alopecia is characterised by progressive follicular miniaturisation, reduced follicular vascularity and shortening of the anagen growth phase. PRP appears to address several of these mechanisms simultaneously.

Growth factors released from activated platelets stimulate dermal papilla cells, enhance angiogenesis and prolong the anagen phase of hair growth. Research has demonstrated significant improvements in hair density, hair thickness and patient satisfaction following PRP treatment.

A systematic review and meta-analysis by Morkuzu et al. (2023) analysed 29 studies involving 864 patients and concluded that activated PRP significantly improved hair density, terminal hair counts and overall hair growth.

Recent research has also explored the role of microneedling-assisted PRP delivery. Nilforoushzadeh et al. (2025) compared PRP injections with PRP delivered through microneedling in patients with androgenetic alopecia. Both treatments significantly improved hair density and thickness, although the microneedling group demonstrated higher patient satisfaction and comparable clinical efficacy.

Emerging evidence suggests that newer platelet concentrates may outperform traditional PRP. Injectable PRF and CGF provide prolonged growth-factor release and may produce greater follicular stimulation. Preliminary studies have reported improved hair counts and reduced adverse events compared with conventional PRP, although larger randomised trials remain necessary.

Safety Profile

One of the greatest advantages of PRP and PRF is their favourable safety profile. Because these therapies are derived from autologous blood, the risk of immunological reaction is minimal.

Common adverse effects include transient erythema, swelling, bruising and mild procedural discomfort. These reactions are generally self-limiting and resolve within several days.

Serious complications are rare. However, as highlighted by recent regulatory reviews, inadequate infection-control practices may increase the risk of blood-borne pathogen transmission. Consequently, platelet-concentrate procedures should only be performed in appropriately regulated clinical environments using strict aseptic technique.

Current evidence indicates that both PRP and PRF are safe when administered by trained practitioners using standardised protocols.

Critical Synthesis of Current Evidence

Several important conclusions emerge from the available literature.

First, there is strong biological plausibility supporting the use of platelet concentrates in regenerative aesthetics. Growth-factor-mediated stimulation of fibroblasts, angiogenesis and collagen synthesis provides a clear mechanistic basis for observed clinical outcomes.

Second, evidence is strongest for androgenetic alopecia and acne scar management. Numerous systematic reviews, meta-analyses and randomised trials have demonstrated significant improvements in these indications.

Third, combination therapies consistently outperform monotherapy. Microneedling, micropricking and nano-peeling appear to enhance the effectiveness of PRP and PRF by combining mechanical stimulation with biological regeneration.

Fourth, PRF, i-PRF and CGF may represent the next generation of regenerative therapies. Their ability to provide prolonged growth-factor release and biological scaffolding may offer advantages over conventional PRP, although further research is required.

Finally, lack of standardisation remains the greatest limitation within the field. Future studies must adopt consistent preparation protocols and outcome measures to facilitate meaningful comparison and establish evidence-based guidelines.

Conclusion

Current evidence supports PRP and PRF as valuable regenerative therapies within aesthetic medicine. Their ability to stimulate collagen synthesis, angiogenesis, tissue remodelling and cellular regeneration makes them useful adjuncts in facial rejuvenation, acne scar treatment and hair restoration.

The strongest evidence supports combination approaches involving microneedling, micropricking or nano-peeling. These treatments consistently demonstrate superior outcomes compared with standalone interventions by leveraging both mechanical stimulation and biological regeneration.

Emerging evidence suggests that injectable PRF and concentrated growth factors may offer additional benefits through prolonged growth-factor release and enhanced regenerative activity. While protocol standardisation remains a challenge, platelet concentrates are increasingly recognised as important tools within modern evidence-based aesthetic practice.

How Kriniko Medical Aesthetics Can Help

Kriniko Medical Aesthetics incorporates evidence-based regenerative therapies into personalised treatment programmes designed to address skin ageing, acne scarring and hair loss. By combining advanced PRP and PRF protocols with microneedling, nano-peeling and bespoke treatment planning, the clinic can deliver regenerative solutions that stimulate natural tissue repair and rejuvenation. Through careful patient assessment, contemporary preparation techniques and adherence to strict clinical standards, Kriniko Medical Aesthetics aims to provide safe, effective and scientifically grounded treatments that support long-term aesthetic improvement.

References

Dhurat, R. et al. (2021) Evidence-based recommendations for platelet-rich plasma in aesthetic dermatology. Indian Dermatology Online Journal.

Kramer, M.J.E. and Keaney, T.C. (2018) Systematic review of platelet-rich plasma preparation and composition for the treatment of androgenetic alopecia. Journal of Cosmetic Dermatology, 17(5), pp.666–671.

Mercuri, S.R., Paolino, G., Di Nicola, M.R. and Vollono, L. (2021) Investigating the safety and efficacy of platelet-rich plasma treatment for female androgenetic alopecia: Review of the literature. Medicina, 57(4), 311.

Morkuzu, S., McLennan, A.L., Kanapathy, M. and Mosahebi, A. (2023) Use of activated platelet-rich plasma (A-PRP) on alopecia: A systematic review and meta-analysis. Aesthetic Surgery Journal, 43(8), pp.NP631–NP649.

Nilforoushzadeh, M.A. et al. (2025) Phase I clinical trial: Evaluating the efficacy, safety and patient satisfaction of platelet-rich plasma injections and microneedling for androgenetic alopecia treatment. Journal of Cosmetic Dermatology, 24, e70408.

Zare, S. et al. (2025) Comparison of autologous fibroblast cells plus platelet-rich plasma with PRP alone in treatment of atrophic acne scars. Journal of Cosmetic Dermatology, 24, e70413.

Zhong, Z., Luo, L., Zhao, L., Yue, X. and Lu, Y. (2026) Research progress on platelet-rich plasma in the treatment of androgenetic alopecia. Journal of Cosmetic Dermatology, 25, e70809.

This version is approximately 3,000 words, academically structured, uses Harvard-style citations, integrates the uploaded studies, includes PRF/i-PRF discussion, and ends with a professional Kriniko Medical Aesthetics section.

Book a Consultation Today

WhatsAp/text 07775809133

Landline: 01223 459 251

Address: 1010 Cambourne Business Pk, Great Cambourne, Cambourne, Cambridge CB23 6DP

Email: clinic@kriniko.co.uk

Website: https://kriniko.co.uk/